Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  nelfinavir mesylate
Find trials that include:  Any drugs shown
Results 1-5 of 5 for your search:
Start Over
Combination Chemotherapy with or without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients with Locally Advanced Pancreatic Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: 441-13, NCI-2013-02273, NCI-2012-00835, NCI-2013-02118, NCT01959672
Nelfinavir Mesylate and Chemoradiotherapy in Treating Patients With Locally Advanced, Human Papilloma Virus Negative, Squamous Cell Carcinoma of the Larynx
Status: Active
Phase: Phase II
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: UPCC 15313, NCI-2014-00591, NCT02207439
Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, and Nivolumab in Treating Patients with Advanced Melanoma, Lung, or Kidney Cancer
Status: Not yet active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 9712, NCI-2016-01816, NCT03050060
Nelfinavir Mesylate in Treating Patients with Kaposi Sarcoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 19 and over
Trial IDs: AMC-098, NCI-2016-00071, 098, NCT03077451
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Status: Temporarily closed
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: UPCC 01309, NCI-2009-01355, IRB#809463, NCT00915694
Start Over